PERCEPTION OF COMMUNITY PHARMACIST TOWARD WEIGHT LOSS PRODUCTS: KAHRAMANMARAŞ CITY SAMPLE

Yıl 2022, , 955 - 966, 30.09.2022

Nilay Aksoy , Nazlı Gül Erdoğan

https://doi.org/10.33483/jfpau.1147465

Öz

Objective: The purpose of this study is to better understand the role of community pharmacists in obesity management by observing their knowledge of weight loss drugs, analyzing their attitudes and behaviors toward patients, and determining their transfer patterns to patients.
Material and Method: After ethical approval, a cross-sectional study was conducted using an online questionnere via a Google online form. The research population consists of community pharmacists working in the province of Kahramanmaraş. The questionnaire was designed to assess Community pharmacists' knowledge and attitudes toward weight loss products. The data was then analyzed using the SPSS for Windows 26.0 program (Statistical Package for Social Sciences).
Result and Discussion: Eighty-six percent of the pharmacists reported always/often counselling customers who request to buy products for weigh management on the safe and effective use of the product and 69.9% always/often check for drug or food interaction while dispensing weight loss products. The majority of Community pharmacists (72.8%) agreed that continuous education of the pharmacist should include weight management and training. Pharmacists surveyed have a moderate knowledge of weight loss products. Time, staff, budget were the barriers to offering pharmacy weight management services. Continuing education, supporting pharmacists with sufficient resources, and conducting more comprehensive research can play a critical role in the fight against obesity.

Anahtar Kelimeler

Community pharmacists, knowledge, obesity, perception, weight loss

Destekleyen Kurum

No fund

TOPLUM ECZACILARININ KİLO VERME ÜRÜNLERİNE KARŞI ALGISI: KAHRAMANMARAŞ İLİ ÖRNEĞİ

Öz

Amaç: Bu çalışmanın amacı, toplum eczacıların kilo verme ilaçları hakkındaki bilgilerini gözlemleyerek, hastalara yönelik tutum ve davranışlarını analiz ederek ve hastalara aktarım şekillerini belirleyerek obezite yönetimindeki rolünü daha iyi anlamaktır.
Gereç ve Yöntem: Etik onaydan sonra, çevrimiçi Google formu aracılığıyla bir anket uygulanarak kesitsel bir çalışma yapılmıştır. Araştırma Kahramanmaraş ilinde çalışan toplum eczacılar üzerinden yürütülmüştür. Anketler, toplum eczacıların zayıflama ürünlerine yönelik bilgi ve tutumlarını değerlendirmek için tasarlanmıştır. Veriler daha sonra Windows 26.0 için SPSS programı (Statistical Package for Social Sciences) kullanılarak analiz edilmilştir.
Sonuçlar ve Tartışma: Yüzde seksen altı, kilo yönetimi için ürün satın almak isteyen müşterilere ürünün güvenli ve etkili kullanımı konusunda her zaman/sıklıkla danışmanlık yaptığını ve %69,9'u zayıflama ürünlerini dağıtırken ilaç-gıda etkileşimini her zaman/sıklıkla kontrol ettiğini bildirdi. toplum Eczacıların çoğunluğu (%72,8) eczacının sürekli eğitiminin kilo yönetimi ve eğitimini içermesi gerektiği konusunda hemfikirdi.
Ankete katılan eczacılar, kilo verme ürünleri hakkında orta düzeyde bilgiye sahipti. Zaman, personel ve bütçe kısıtlılığı, eczacıların kilo yönetimi hizmetleri sunmalarının önünde engeldir. Eczacıların mezun olduktan sonra kilo yönetimi konusunda eğitimlerinin devam etmesi, etkili kilo yönetimi hizmetleri sunmaları için yeterli kaynaklarla eczacıların desteklenmesi ve daha kapsamlı araştırmalar yapılması obezite ile mücadelede kritik rol oynayabilir.

Anahtar Kelimeler

Algı, bilgi, kilo verme, obezite, toplum eczacıları

Kaynakça

• 1. Hruby, A., Hu, F. B. (2014). The epidemiology of obesity: A big picture. PharmacoEconomics, 33(7), 673–689. [CrossRef]
• 2. Bhat, S. P., Sharma, A. (2017). Current drug targets in obesity pharmacotherapy – A review. Current Drug Targets, 18(8), 983–993. [CrossRef]
• 3. Kissane, N. A., Pratt, J. S. (2011). Medical and surgical treatment of obesity. Best practice & research. Clinical anaesthesiology, 25(1), 11–25. [CrossRef]
• 4. Clements, J. N., Shealy, K. M. (2015). Liraglutide: An injectable option for the management of obesity. The Annals of Pharmacotherapy, 49(8), 938–944. [CrossRef]
• 5. Whitten, J. S. (2016). Liraglutide (Saxenda) for weight loss. American Family Physician, 94(2), 161-166.
• 6. Rosenthal, M., Ward, L. M., Teng, J., Haines, S. (2018). Weight management counselling among community pharmacists: A scoping review. The International Journal of Pharmacy Practice, 26(6), 475–484. [CrossRef]
• 7. Um, I. S., Krass, I., Armour, C., Gill, T., Chaar, B. B. (2015). Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program. International Journal of Clinical Pharmacy, 37(5), 822–833. [CrossRef]
• 8. Boardman, H. F., Avery, A. J. (2014). Effectiveness of a community pharmacy weight management programme. International Journal of Clinical Pharmacy, 36(4), 800–806. [CrossRef]
• 9. Gómez-Martinez, J., López-Pintor, E., Lumbreras, B. (2020). Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study. Patient Preference and Adherence, 14, 1501–1511. [CrossRef] 10. Hijazi, M. A., Shatila, H., El-Lakany, A., Al Rifai, H., Aboul-Ela, M., Naja, F. (2020). Role of community pharmacists in weight management: Results of a national study in Lebanon. BMC Health Services Research, 20(1), 386. [CrossRef]
• 11. AlMukdad, S., Zaghloul, N., Awaisu, A., Mahfoud, Z. R., Kheir, N., El Hajj, M. S. (2021). Exploring the role of community pharmacists in obesity and weight management in Qatar: A Mixed-Methods Study. Risk Management and Healthcare Policy, 14, 2771–2787. [CrossRef]
• 12. Bates, I., John, C., Bruno, A., Fu, P., Aliabadi, S. (2016). An analysis of the global pharmacy workforce capacity. Human Resources for Health, 14(1), 61. [CrossRef]
• 13. Newlands, R. S., Watson, M. C., Lee, A. J. (2011). The provision of current and future Healthy Weight Management (HWM) services from community pharmacies: A survey of community pharmacists' attitudes, practice and future possibilities. The International Journal of Pharmacy Practice, 19(2), 106–114. [CrossRef]
• 14. Fakih, S., Marriott, J. L., Hussainy, S. Y. (2015). A national mailed survey exploring weight management services across Australian community pharmacies. Australian Journal of Primary Health, 21(2), 197–204. [CrossRef]
• 15. Krska, J., Lovelady, C., Connolly, D., Parmar, S., Davies, M. J. (2010). Community pharmacy contribution to weight management: Identifying opportunities. The International Journal of Pharmacy Practice, 18(1), 7–12. [CrossRef]
• 16. Lunsford, K. E., Bodzin, A. S., Reino, D. C., Wang, H. L., Busuttil, R. W. (2016). Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation. World Journal of Gastroenterology, 22(45), 10071–10076. [CrossRef]
• 17. Yen, M., Ewald, M. B. (2012). Toxicity of weight loss agents. Journal of medical toxicology: Official journal of the American College of Medical Toxicology, 8(2), 145–152. [CrossRef]
• 18. Nimptsch, K., Konigorski, S., Pischon, T. (2019). Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism: Clinical and Experimental, 92, 61–70. [CrossRef]
• 19. Zieck, M., Um, I. S., Chaar, B. B. (2018). The future of weight management in pharmacy education - Perspectives of new generation pharmacists. Currents in Pharmacy Teaching & Learning, 10(5), 596–601. [CrossRef]
• 20. Awad, A., Waheedi, M. (2012). Community Pharmacists role in obesity treatment in Kuwait: A cross-sectional study. BMC Public Health, 12, 863. [CrossRef]
• 21. Peletidi, A., Kayyali, R. (2019). Experiences of the pharmacy-led weight management service: Views of service providers in England. Pharmacy, 7(3), 82. [CrossRef]
• 22. Verma, R. K., Paraidathathu, T., Taha, N. A., Chong, W. W. (2019). Attitudes, practices, and barriers of Malaysian community pharmacists toward provision of weight management services. Frontiers in Pharmacology, 10, 138. [CrossRef]
• 23. Ahrens, R. A., Hower, M., Best, A. M. (2003). Effects of weight reduction interventions by community pharmacists. Journal of the American Pharmacists Association, 43(5), 583-589. [CrossRef]
• 24. Clements, J. N., Albanese, N. P., D'Souza, J. J., Misher, A., Reece, S., Trujillo, J., Whitley, H. P. (2021). Clinical review and role of clinical pharmacists in obesity management: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 4(11), 1469-1484. [CrossRef]